AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


As a result of the COVID-19 pandemic, laboratories have faced challenges in lack of highly qualified clinical laboratory scientists. AACC is making the case that stronger support of clinical laboratories and a focus on high standards must be part of the solution and is calling for more funding for lab…
Emicizumab was first approved by the Food and Drug Administration in 2017 to treat hemophilia A in patients with FVIII inhibitors. As patients without FVIII inhibitors also start taking this medication, clinical and laboratory experts provide insights about the most appropriate diagnostic testing for monitoring and managing patients taking this…

Ask the Expert


Bench Matters


Federal Insider


Industry Playbook


Regulatory Roundup


Special Supplement


AACC, Abbott, and other leading healthcare organizations this year continued special recognition for a number of interdisciplinary teams through the UNIVANTS of Healthcare Excellence program. Teams are judged on initiatives that achieve measurable, innovative impact within healthcare systems.

The Sample